Dr Pascale Morel has been working in the pharmaceutical industry in various international roles, such as Marketing, Clinical Development and Medical Affairs. Pascale has also worked in the clinical diagnostics and Life Sciences sector at companies like Nanostring or Guardant Heath. Her career has a strong focus on oncology and haemato-oncology, in scope of drug clinical development, clinical genomics and molecular biology, including contributing to the effort of introducing liquid biopsies testing from the industry perspective. Pascale now serves as Senior Medical Affairs Director for the Translational Sciences and Precision Diagnostics franchise at Qiagen, where her mission fits her professional priority which is to contribute in implementing clinical diagnostics tools to make personalized medicine more and more a reality for patients.